Monitoring Src status after dasatinib treatment in HER2+ breast cancer with (89)Zr-trastuzumab PET imaging

por McKnight, Brooke N., Viola-Villegas, Nerissa T.
Publicado 2018

Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer

por McKnight, Brooke N., Kim, Seongho, Boerner, Julie L., Viola, Nerissa T.
Publicado 2020

Pancreatic SEC23B deficiency is sufficient to explain the perinatal lethality of germline SEC23B deficiency in mice

por Khoriaty, Rami, Everett, Lesley, Chase, Jennifer, Zhu, Guojing, Hoenerhoff, Mark, McKnight, Brooke, Vasievich, Matthew P., Zhang, Bin, Tomberg, Kärt, Williams, John, Maillard, Ivan, Ginsburg, David
Publicado 2016

Imaging EGFR and HER3 through (89)Zr-labeled MEHD7945A (Duligotuzumab)

por McKnight, Brooke N., Kuda-Wedagedara, Akhila N. W., Sevak, Kuntal K., Abdel-Atti, Dalya, Wiesend, Wendy N., Ku, Anson, Selvakumar, Dakshnamurthy, Carlin, Sean D., Lewis, Jason S., Viola-Villegas, Nerissa T.
Publicado 2018

SEC23B is required for pancreatic acinar cell function in adult mice

por Khoriaty, Rami, Vogel, Nancy, Hoenerhoff, Mark J., Sans, M. Dolors, Zhu, Guojing, Everett, Lesley, Nelson, Bradley, Durairaj, Haritha, McKnight, Brooke, Zhang, Bin, Ernst, Stephen A., Ginsburg, David, Williams, John A.
Publicado 2017